Pain Therapeutics reported $-17821000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2912M 534M
Acelrx Pharmaceuticals ACRX:US $ -8995000 820K
Acura Pharmaceuticals ACUR:US -300000 154K
Amgen AMGN:US $ 2500M 196M
Biogen BIIB:US $ 610.7M 23.6M
Cara Therapeutics CARA:US $ -27911000 5.61M
Eisai 4523:JP Y -20803M 34451M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Geron GERN:US $ -28.68M 2.31M
Johnson & Johnson JNJ:US $ 5862M 1026M
Merk MRK:US $ 5569M 1994M
Novartis NOVN:VX 2.85B 290M
Novavax NVAX:US $ 209.29M 1034.26M
Pain Therapeutics PTIE:US $ -17821000 3.38M
Pfizer PFE:US $ 9873M 5297M